These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 26954680)
1. Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression. Huang CK; Iwagami Y; Aihara A; Chung W; de la Monte S; Thomas JM; Olsen M; Carlson R; Yu T; Dong X; Wands J PLoS One; 2016; 11(3):e0150336. PubMed ID: 26954680 [TBL] [Abstract][Full Text] [Related]
2. Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk. Barboro P; Benelli R; Tosetti F; Costa D; Capaia M; Astigiano S; Venè R; Poggi A; Ferrari N Carcinogenesis; 2020 Sep; 41(9):1246-1252. PubMed ID: 32525968 [TBL] [Abstract][Full Text] [Related]
3. Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation. Huang CK; Iwagami Y; Zou J; Casulli S; Lu S; Nagaoka K; Ji C; Ogawa K; Cao KY; Gao JS; Carlson RI; Wands JR Cancer Lett; 2018 Aug; 429():1-10. PubMed ID: 29733964 [TBL] [Abstract][Full Text] [Related]
4. Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis. Nagaoka K; Ogawa K; Ji C; Cao KY; Bai X; Mulla J; Cheng Z; Wands JR; Huang CK Dig Dis Sci; 2021 Apr; 66(4):1080-1089. PubMed ID: 32445050 [TBL] [Abstract][Full Text] [Related]
5. Diverse molecular functions of aspartate β‑hydroxylase in cancer (Review). Zheng W; Wang X; Hu J; Bai B; Zhu H Oncol Rep; 2020 Dec; 44(6):2364-2372. PubMed ID: 33125119 [TBL] [Abstract][Full Text] [Related]
6. A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma. Aihara A; Huang CK; Olsen MJ; Lin Q; Chung W; Tang Q; Dong X; Wands JR Hepatology; 2014 Oct; 60(4):1302-13. PubMed ID: 24954865 [TBL] [Abstract][Full Text] [Related]
7. Aspartate β-hydroxylase as a target for cancer therapy. Kanwal M; Smahel M; Olsen M; Smahelova J; Tachezy R J Exp Clin Cancer Res; 2020 Aug; 39(1):163. PubMed ID: 32811566 [TBL] [Abstract][Full Text] [Related]
8. Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype. Dong X; Lin Q; Aihara A; Li Y; Huang CK; Chung W; Tang Q; Chen X; Carlson R; Nadolny C; Gabriel G; Olsen M; Wands JR Oncotarget; 2015 Jan; 6(2):1231-48. PubMed ID: 25483102 [TBL] [Abstract][Full Text] [Related]
9. Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma. Nagaoka K; Bai X; Ogawa K; Dong X; Zhang S; Zhou Y; Carlson RI; Jiang ZG; Fuller S; Lebowitz MS; Ghanbari H; Wands JR Cancer Lett; 2019 May; 449():87-98. PubMed ID: 30768955 [TBL] [Abstract][Full Text] [Related]
10. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma. Iwagami Y; Huang CK; Olsen MJ; Thomas JM; Jang G; Kim M; Lin Q; Carlson RI; Wagner CE; Dong X; Wands JR Hepatology; 2016 Apr; 63(4):1213-26. PubMed ID: 26683595 [TBL] [Abstract][Full Text] [Related]
11. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763 [TBL] [Abstract][Full Text] [Related]
12. Aspartate β-hydroxylase (ASPH) Accelerates Intrahepatic Cholangiocarcinoma Metastasis Zou Y; Lin J; Liu J; Zhang F; Yang T; Gong J; Jiang T; Zuo J; Song R; Shen H; Shen F; Li J Curr Protein Pept Sci; 2023; 24(5):436-446. PubMed ID: 37132101 [TBL] [Abstract][Full Text] [Related]
13. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Bai X; Sun B; Hung MC; Liu L; Wands J; Dong X Mol Cancer; 2019 Nov; 18(1):156. PubMed ID: 31694640 [TBL] [Abstract][Full Text] [Related]
14. Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors. Brewitz L; Tumber A; Pfeffer I; McDonough MA; Schofield CJ Sci Rep; 2020 May; 10(1):8650. PubMed ID: 32457455 [TBL] [Abstract][Full Text] [Related]
15. Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase. Nagaoka K; Bai X; Liu D; Cao K; Mulla J; Ji C; Chen H; Nisar MA; Bay A; Mueller W; Hildebrand G; Gao JS; Lu S; Setoyama H; Tanaka Y; Wands JR; Huang CK Cancer Lett; 2024 Jan; 580():216493. PubMed ID: 37977350 [TBL] [Abstract][Full Text] [Related]
16. Kinetic parameters of human aspartate/asparagine-β-hydroxylase suggest that it has a possible function in oxygen sensing. Brewitz L; Tumber A; Schofield CJ J Biol Chem; 2020 Jun; 295(23):7826-7838. PubMed ID: 32107312 [TBL] [Abstract][Full Text] [Related]
17. Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma. Shimoda M; Tomimaru Y; Charpentier KP; Safran H; Carlson RI; Wands J J Hepatol; 2012 May; 56(5):1129-1135. PubMed ID: 22245894 [TBL] [Abstract][Full Text] [Related]
18. Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway. Zou Q; Hou Y; Wang H; Wang K; Xing X; Xia Y; Wan X; Li J; Jiao B; Liu J; Huang A; Wu D; Xiang H; Pawlik TM; Wang H; Lau WY; Wang Y; Shen F EBioMedicine; 2018 May; 31():287-298. PubMed ID: 29764768 [TBL] [Abstract][Full Text] [Related]
19. Methods for production and assaying catalysis of isolated recombinant human aspartate/asparagine-β-hydroxylase. Brewitz L; Brasnett A; Schnaubelt LI; Rabe P; Tumber A; Schofield CJ Methods Enzymol; 2024; 704():313-344. PubMed ID: 39300654 [TBL] [Abstract][Full Text] [Related]
20. Corilagin suppresses cholangiocarcinoma progression through Notch signaling pathway in vitro and in vivo. Gu Y; Xiao L; Ming Y; Zheng Z; Li W Int J Oncol; 2016 May; 48(5):1868-76. PubMed ID: 26935808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]